Jaguar Health

$Jaguar Health(JAGX)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001193125-25-293746  Act: 33  Size: 12 KB 网页链接

$Jaguar Health(JAGX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001851416-25-000028  Act: 34  Size: 9 KB 网页链接

$Jaguar Health(JAGX)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-25-283139  Act: 34  Size: 518 KB 网页链接

$Jaguar Health(JAGX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001185185-26-000024  Act: 34  Size: 6 KB 网页链接

$Jaguar Health(JAGX)$ Iliad Research & Trading, L.P.及其关联实体Iliad Management, LLC、Fife Trading, Inc.以及个人John M. Fife已报告获得Jaguar Health, Inc.普通股440,000股的实益所有权。截至2025年12月11日，此次收购占该公司已发行股份的9.8%。申报文件显示，这些股份的收购目的并...

$Jaguar Health(JAGX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001193125-26-009644  Act: 34  Size: 348 KB 网页链接

$Jaguar Health(JAGX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001193125-26-009221  Act: 34  Size: 506 KB 网页链接

$Jaguar Health(JAGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-018044  Size: 7 KB 网页链接

$Jaguar Health(JAGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-018042  Size: 7 KB 网页链接

$Jaguar Health(JAGX)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-25-317693  Act: 34  Size: 161 KB 网页链接

$Jaguar Health(JAGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-319518  Size: 8 KB 网页链接

$Jaguar Health(JAGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-319508  Size: 8 KB 网页链接

$Jaguar Health(JAGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-319513  Size: 8 KB 网页链接

$Jaguar Health(JAGX)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001193125-26-014231  Act: 34  Size: 1 MB 网页链接

$Jaguar Health(JAGX)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-26-021064  Act: 34  Size: 833 KB 网页链接

$Jaguar Health(JAGX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-282950  Act: 34  Size: 23 MB 网页链接

$Jaguar Health(JAGX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001193125-25-287650  Act: 34  Size: 505 KB 网页链接

$Jaguar Health(JAGX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003382  Act: 33  Size: 1 KB 网页链接

$Jaguar Health(JAGX)$ 8-K Current report, items 5.07, 7.01, and 9.01 Accession Number: 0001193125-25-311294  Act: 34  Size: 327 KB 网页链接

$Jaguar Health(JAGX)$ 本文件报告称，Joshua Mailman 实益拥有 Jaguar Health, Inc. 普通股 587,320 股，占该类别股份的 8.4%。Mailman 先生对 337,321 股拥有唯一投票权和处置权，对 249,999 股拥有共同投票权和处置权。该文件证明这些证券并非为影响发行人控制权而收购或持有。报告人的主要业务...